Craig Boerner Archive — Page 4 of 20
-
January 24, 2024
Long-term follow-up pinpoints side effects of treatments for prostate cancer patients
A 10-year follow up study of nearly 2,500 U.S. men who received prostate cancer treatment will help inform decision making in terms of treatments and side effects for a diverse population. -
January 17, 2024
Bird flu vaccine more effective with potent adjuvant
The avian (bird) influenza vaccine creates a more robust immune response when paired with a potent ingredient known as an adjuvant, according to Vanderbilt research published in The Journal of Infectious Diseases. -
October 24, 2023
VUMC seeks public input on blood-clotting agent study
Researchers at Vanderbilt are considering participation in an international study to examine if a blood-clotting medication given to adults with major bleeding or in need of urgent surgery or an invasive procedure can improve survival. -
October 16, 2023
ICU antibiotics may be safe for kidneys
A Vanderbilt study found that two antibiotics thought to cause kidney failure in ICU patients with a severe bacterial infection, especially when combined with another antibiotic, may be safer for the kidneys than previously reported. -
October 5, 2023
Kidney disease gene also has a protective mutation
African Americans have long been known to be at increased risk of kidney disease due to a dangerous genetic mutation that creates a hole in the kidney cells, but Vanderbilt researchers have now discovered a protective genetic mutation that covers the hole to eliminate the risk. -
August 7, 2023
Effective medications for opioid use disorder rarely used
Vanderbilt research shows that most individuals diagnosed with opioid use disorder are not on recommended medications and even fewer remain in care.